IE45877L - Delta-1,4-pregnadienes - Google Patents

Delta-1,4-pregnadienes

Info

Publication number
IE45877L
IE45877L IE772011A IE201177A IE45877L IE 45877 L IE45877 L IE 45877L IE 772011 A IE772011 A IE 772011A IE 201177 A IE201177 A IE 201177A IE 45877 L IE45877 L IE 45877L
Authority
IE
Ireland
Prior art keywords
pregnadienes
delta
prednisolone
chloro
derived
Prior art date
Application number
IE772011A
Other versions
IE45877B1 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2645105A external-priority patent/DE2645105C2/en
Priority claimed from DE19772742982 external-priority patent/DE2742982C2/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of IE45877L publication Critical patent/IE45877L/en
Publication of IE45877B1 publication Critical patent/IE45877B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Derived from the chloro-9 prednisolone. They correspond to the formula: [FR2366313A1]
IE2011/77A 1976-10-04 1977-10-03 New derivatives of 9-chloroprednisolone IE45877B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2645105A DE2645105C2 (en) 1976-10-04 1976-10-04 Derivatives of 9-chlorprednisolone, process for their preparation and pharmaceutical preparation containing them
DE19772742982 DE2742982C2 (en) 1977-09-21 1977-09-21 9-chlorprednisolone derivatives, process for their production and pharmaceutical preparation containing them

Publications (2)

Publication Number Publication Date
IE45877L true IE45877L (en) 1978-04-04
IE45877B1 IE45877B1 (en) 1982-12-15

Family

ID=25770978

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2011/77A IE45877B1 (en) 1976-10-04 1977-10-03 New derivatives of 9-chloroprednisolone

Country Status (21)

Country Link
JP (1) JPS5359654A (en)
AT (1) AT358202B (en)
CH (4) CH630098A5 (en)
DK (1) DK438277A (en)
ES (1) ES462887A1 (en)
FI (1) FI58645C (en)
FR (1) FR2366313A1 (en)
GB (1) GB1594852A (en)
GR (1) GR73041B (en)
HU (1) HU179593B (en)
IE (1) IE45877B1 (en)
IL (1) IL53030A (en)
IT (1) IT1113623B (en)
LU (1) LU78223A1 (en)
NL (1) NL7710869A (en)
NO (1) NO148597C (en)
NZ (1) NZ185295A (en)
PL (1) PL110392B1 (en)
PT (1) PT67109B (en)
SE (1) SE431655B (en)
SU (2) SU743581A3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853785A1 (en) * 1978-12-11 1980-06-19 Schering Ag NEW PREDNISON DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND THE USE THEREOF
JPH0374245A (en) * 1989-08-12 1991-03-28 Mk Seiko Co Ltd car wash machine
BR112012024289A2 (en) 2010-03-26 2017-07-18 Galderma Res & Dev "Method to Provide Safe and Effective Treatment of Erythema and Topical Gel Composition"
US9744168B2 (en) 2011-10-19 2017-08-29 Galderma Laboratories, Inc. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
CN106632561A (en) * 2016-12-16 2017-05-10 广州仁恒医药科技股份有限公司 Method for preparing difluprednate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1195748B (en) * 1961-06-24 1965-07-01 Vismara Francesco Spa Process for the preparation of 1'-substituted 17alpha, 21- (1'-alkoxy) -methylenedioxysteriodes
DE2055221A1 (en) * 1970-11-10 1972-05-18 Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand (Italien) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride

Also Published As

Publication number Publication date
FI58645B (en) 1980-11-28
SE431655B (en) 1984-02-20
PL201161A1 (en) 1979-01-29
SU751327A3 (en) 1980-07-23
CH632278A5 (en) 1982-09-30
ATA703577A (en) 1980-01-15
CH631997A5 (en) 1982-09-15
CH632772A5 (en) 1982-10-29
PT67109A (en) 1977-11-01
SU743581A3 (en) 1980-06-25
ES462887A1 (en) 1978-12-16
CH630098A5 (en) 1982-05-28
NZ185295A (en) 1980-04-28
AT358202B (en) 1980-08-25
NO148597B (en) 1983-08-01
GB1594852A (en) 1981-08-05
DK438277A (en) 1978-04-05
FI58645C (en) 1981-03-10
IE45877B1 (en) 1982-12-15
FR2366313A1 (en) 1978-04-28
HU179593B (en) 1982-11-29
PL110392B1 (en) 1980-07-31
NO148597C (en) 1983-11-09
JPS5359654A (en) 1978-05-29
GR73041B (en) 1984-01-26
SE7711039L (en) 1978-04-05
IL53030A (en) 1982-11-30
FR2366313B1 (en) 1980-02-01
IT1113623B (en) 1986-01-20
JPS6129960B2 (en) 1986-07-10
IL53030A0 (en) 1977-11-30
NL7710869A (en) 1978-04-06
LU78223A1 (en) 1978-02-01
NO773362L (en) 1978-04-05
PT67109B (en) 1979-03-14
FI772922A7 (en) 1978-04-05

Similar Documents

Publication Publication Date Title
AU505080B2 (en) 2-piperazinyl-6, 7-dimethoxyquinazolines
IE39078L (en) Substituted 1,3,5 - triazines.
AU1622176A (en) 4,5-dihydro-2-lower-alkoxycarbonyl-amino-4 phenylimidazoles
AU516654B2 (en) 2-FORMYLQUINOXALINE-l, 4-DIOXIDE
AU498333B2 (en) 7-substituted-benzo-1, 2, 4-triazine-3-ethers
IE45108L (en) Vitamin product
AU510619B2 (en) 3-substituted-4-aminoalcoxy-5, 6-condensed ring-(2h)-pyran-2-ones
AU520355B2 (en) 2-arylamino-3,5dinitro-benzotrifluorides
CA1029374A (en) 2-substituted-5,6-dimethoxyindazoles
IE45877L (en) Delta-1,4-pregnadienes
AU512313B2 (en) y, y, Disubstituted-5-valerolactones
AU502683B2 (en) Thiopyrano-4, 3-c-pyrazoles
AU508891B2 (en) 5,6-dihydro-prostacyclin analogs
IE780186L (en) Imidazopyridazines
AU500164B2 (en) 3, 4, 5-substituted benzenesulfonformamidines
AU520625B2 (en) 1-acyl-2-hydroxy-1, 3-diaminopropanes
AU499442B2 (en) 1, 4 benzodioxanes
AU515885B2 (en) SUBSTITUTED 1-PIPERAZINO-TRIAZOLO-THIENO-l, 4-DIAZEPINES
AU511827B2 (en) 5-anyl-3, 6-dihydro-l, 3, 4-oxadiazin-2-ones
AU506922B2 (en) N-6-chlorunicotinoyl-d, l-homocysteing thiolactonne
AU1068676A (en) 6,11-dihydrodibenzo-thiepin-11-ones
AU1133876A (en) 1, 3-dialkyl-7-oxoalkylxanthines
AU494288B2 (en) 2-tetrahydrofurfuryl-6, 7-benzomorphanes
AU500148B2 (en) Herbicidal, composition
AU484466B2 (en) 1,3-dihydrospiro isobenzofuran s